UBS Group’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.7K Sell
2,847
-1,193
-30% -$17.9K ﹤0.01% 6599
2025
Q1
$70K Sell
4,040
-3,472
-46% -$60.1K ﹤0.01% 6050
2024
Q4
$104K Buy
7,512
+6,646
+767% +$91.8K ﹤0.01% 5636
2024
Q3
$11.7K Sell
866
-3,314
-79% -$45K ﹤0.01% 6455
2024
Q2
$73.8K Buy
4,180
+2,723
+187% +$48.1K ﹤0.01% 5247
2024
Q1
$34.3K Buy
+1,457
New +$34.3K ﹤0.01% 5506
2023
Q2
Sell
-24
Closed -$775 8458
2023
Q1
$775 Sell
24
-171
-88% -$5.52K ﹤0.01% 7804
2022
Q4
$5.15K Sell
195
-149
-43% -$3.93K ﹤0.01% 8015
2022
Q3
$13K Buy
+344
New +$13K ﹤0.01% 6970
2022
Q1
Sell
-422
Closed -$17K 9657
2021
Q4
$17K Buy
+422
New +$17K ﹤0.01% 6965
2021
Q3
Sell
-265
Closed -$24K 8817
2021
Q2
$24K Buy
265
+167
+170% +$15.1K ﹤0.01% 6064
2021
Q1
$11K Sell
98
-138
-58% -$15.5K ﹤0.01% 6844
2020
Q4
$18K Buy
236
+22
+10% +$1.68K ﹤0.01% 6007
2020
Q3
$15K Buy
214
+106
+98% +$7.43K ﹤0.01% 5665
2020
Q2
$9K Buy
108
+83
+332% +$6.92K ﹤0.01% 6241
2020
Q1
$2K Hold
25
﹤0.01% 6729
2019
Q4
$2K Hold
25
﹤0.01% 6772
2019
Q3
$2K Sell
25
-229
-90% -$18.3K ﹤0.01% 6783
2019
Q2
$14K Buy
254
+187
+279% +$10.3K ﹤0.01% 5983
2019
Q1
$5K Sell
67
-95
-59% -$7.09K ﹤0.01% 6352
2018
Q4
$18K Sell
162
-88
-35% -$9.78K ﹤0.01% 5958
2018
Q3
$8K Buy
250
+223
+826% +$7.14K ﹤0.01% 6370
2018
Q2
$2K Buy
27
+2
+8% +$148 ﹤0.01% 6809
2018
Q1
$4K Buy
25
+7
+39% +$1.12K ﹤0.01% 6456
2017
Q4
$4K Buy
18
+12
+200% +$2.67K ﹤0.01% 6498
2017
Q3
$1K Sell
6
-2
-25% -$333 ﹤0.01% 6670
2017
Q2
$1K Buy
8
+2
+33% +$250 ﹤0.01% 6570
2017
Q1
$2K Sell
6
-24
-80% -$8K ﹤0.01% 6374
2016
Q4
$6K Buy
+30
New +$6K ﹤0.01% 6194